Dr. Emanuele Puca will give an oral presentation entitled: “Antibody-cytokine Fusions for Cancer Therapy: Late-Stage Clinical Results” Dr. Roberto de Luca will give an oral presentation entitled: “Engineering Antibody-Cytokine Fusion...
Read moreFollowing last night’s announcement regarding OncoACP3, we are pleased to invite you to a webinar with Prof. Dario Neri, taking place today, June 11, at 11:00 ET | 17:00 CET. Please...
Read moreOur certified radiation protection experts, Dr. Jacqueline Mock and Dr. Sebastian Oehler, will take part and represent Philochem in the Swiss Radiopharmacy Day.
Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted small molecule therapeutics on March 5 (main session), entitled “Detailing Clinical Development of OncoFAP: a Small Molecule Conjugate Targeting Fibroblast Activation...
Read moreAndrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”. Dr....
Read moreDr. Samuele Cazzamalli, Head of Chemistry at Philochem, will be awarded the 2024 EFMC Prize for Young Medicinal Chemist or Chemical Biologist in Industry.